
1Life Healthcare, Inc.
1Life Healthcare, Inc. (ONEM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
onem · stock forecast · 20 analysts (3M) · FMP · updated Dec 4, 2023
Analyst Rating & Consensus
Based on 20 Wall Street analysts in the past 3 months
Hold
20 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$25.00
Consensus
$16.00
-2.9% upside
Low
$10.00
Median: $14 · Last Close: $16.47
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$16.00
-2.9% upside
High Target
$25
51.8%
Low Target
$10
-39.3%
Current Price
$16.47
as of today
Based on analyst price targets, the ONEM stock price prediction for the next 12 months ranges from $10 to $25. The consensus ONEM price forecast of $16.00 implies -2.9% upside from the current price of $16.47.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $16.48 | ↑ 0.09% |
1-day model range: $16.44–$16.53. Peak: $16.53 (+0.09%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ONEM · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-10-27 | Credit Suisse | Downgrade ↓ | Outperform→Neutral |
| 2022-08-15 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2022-07-27 | Stifel | Downgrade ↓ | Buy→Hold |
| 2022-07-25 | Truist Securities | Downgrade ↓ | Buy→Hold |
| 2022-07-22 | SVB Leerink | Maintains | Market Perform→Perform |
| 2022-07-22 | Deutsche Bank | Maintains | Hold→Hold |
| 2022-07-22 | Citigroup | Downgrade ↓ | Buy→Neutral |
| 2022-07-22 | Barclays | Downgrade ↓ | Overweight→Equal Weight |
| 2022-07-12 | Deutsche Bank | Downgrade ↓ | Buy→Hold |
| 2022-07-11 | Evercore ISI Group | Downgrade ↓ | Outperform→In Line |
Wall Street analysts have recently issued updated ratings on 1Life Healthcare, Inc. (ONEM) stock. Of the recent 61 rating actions, 2 were upgrades and 9 were downgrades. 20 analysts currently cover ONEM.
Analyst Recommendation Trends
ONEM analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast ONEM EPS of $— for the current fiscal year, based on estimates from 0 analysts. The ONEM revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ONEM stock forecast is supported by two independent data sources: analyst consensus ratings from 20 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ONEM price target is $16.00 (-2.9% upside), with an analyst consensus of Hold.
The ONEM short-term stock prediction for tomorrow is $16.48 (+0.09%).
1Life Healthcare, Inc. trades on NASDAQ under the ticker ONEM. The ONEM stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 40% of covering analysts.
Frequently asked questions
ONEM forecast · 8 questionsAccording to 20 Wall Street analysts, the average 12-month ONEM price target is $16.00, with a high forecast of $25.00 and a low of $10.00. The median price target is shown in the chart above when available. This implies -2.9% potential upside from the current price of $16.47.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.